Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.7721
-0.07-8.08%
At close: -
$0.7731
0.001000.13%
After Hours: Mar 28, 7:42 PM EDT
Comments
Loading...
Tempest Therapeutics Stock Price, Quotes and Forecasts
TPSTNASDAQ
Tempest Therapeutics (TPST) Forecast
NewsEarningsTempest Therapeutics (TPST) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Tempest Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:TPST | Benzinga
Explore Tempest Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TPST.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Tempest Therapeutics (TPST) stock?
You can purchase shares of Tempest Therapeutics (NASDAQ:TPST) through any online brokerage.
Who are Tempest Therapeutics (TPST) competitors?
Other companies in Tempest Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), bluebird bio (NASDAQ:BLUE), FibroGen (NASDAQ:FGEN) and OS Therapies (AMEX:OSTX).
What is the forecast, or price target, for Tempest Therapeutics (TPST) stock?
Tempest Therapeutics has a consensus price target of $11.40.
What is the current price for Tempest Therapeutics (TPST)?
The stock price for Tempest Therapeutics (NASDAQ: TPST) is $0.7731 last updated March 28, 2025 at 7:42 PM EDT.
Does Tempest Therapeutics (TPST) pay a dividend?
There are no upcoming dividends for Tempest Therapeutics.
When is Tempest Therapeutics (NASDAQ:TPST) reporting earnings?
Tempest Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Tempest Therapeutics (TPST) going to split?
There is no upcoming split for Tempest Therapeutics.
What sector and industry does Tempest Therapeutics (TPST) operate in?
Tempest Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.